Valuable resources presented at the 5th Annual Israeli National Clinical Trial Congress chaired by Dr. Neuman B.R.D CEO

In front of a large crowd of audiences, and in the presence and participation of the top of the Department of Clinical Trials of the Ministry of Health in Israel, Dr. Neuman, B.R.D CEO, chaired the 5th Annual Israeli National Clinical Trial Congress and addressed the opening lecture “How GCP Revision 2, as well as the new FDA (US), EMA (EU) and the Israeli MOH regulatory updated requirements for clinical trials in humans, affecting clinical trials conducted in Israel”